BioCrowd is an institutional research funding platform that helps hospitals, universities, and patient communities raise milestone-based capital when traditional grants fall short.
As federal funding becomes less predictable, institutions need new, compliant capital sources. BioCrowd provides clinical research funding infrastructure that unlocks Donor-Advised Funds, venture philanthropy, and impact investing in biotech.
NIH funding uncertainty is creating a widening capital gap across clinical and translational research. Institutions are experiencing:
Funding shortfalls are forcing institutions to pause or abandon promising research programs.
Promising proof-of-concept work is stalling before it can attract industry funding.
Institutions are scrambling to find new capital sources without the right infrastructure.
By connecting institutions with new capital sources — donor-advised funds, venture philanthropy, and impact-aligned investors — BioCrowd provides the infrastructure research organizations need to keep moving forward.
See How It WorksBioCrowd is the capital-raising layer that sits between advancement, tech transfer, and research administration systems.
Capital Flow
BioCrowd helps hospitals, universities, and research institutes raise capital aligned to scientific and regulatory milestones.
Projects are submitted and approved by universities, hospitals, or research institutes and defined with specific scientific, clinical, and regulatory milestones.
BioCrowd structures milestone-based funding tranches, legal frameworks, reporting models, and donor/investor participation structures.
Donors, foundations, and investors fund institution-approved campaigns. Capital is released only when milestones are achieved.
Institutions provide milestone-based updates on scientific progress, data readouts, regulatory steps, and licensing or partnership discussions.
Accelerate your research funding with our innovation platform designed specifically for academic research institutions and hospital health systems.
BioCrowd is designed specifically for academic medical centers, R1 and R2 university research programs, and hospital-based research organizations seeking compliant, transparent alternatives to traditional NIH grant funding.
Launch a Research Campaign →Discover high-impact biomedical research opportunities and track your investments with unprecedented transparency and control.
Accredited investors may elect to receive alerts regarding institution-supported investment opportunities, including SAFE Note–based or SPV structures linked to research programs. Or donate for a tax deduction and self-direct your contribution to the lab, disease, researcher, or institution of your choice.
Fund a Clinical Breakthrough →BioCrowd helps institutions raise capital from multiple compliant channels.
Tax-efficient philanthropic giving through established DAF sponsors.
Mission-aligned capital from foundations and philanthropic investors.
Returns-seeking capital aligned to scientific and social milestones.
Early-stage equity structures linked to translational research spinouts.
Institution-approved research programs seeking milestone-based capital.